Skip to main content
. 2017 Sep 22;14(6):6815–6822. doi: 10.3892/ol.2017.7028

Table I.

Clinicopathological characteristics of high TSPAN1 expression in 60 patients with esophageal carcinoma.

Groups Patients, n (%) TSPAN1 high expression, n (%) χ2 P-value
Gender
  Male 50 (83.33) 43 (86.00) 0.235 0.628
  Female 10 (16.67) 8 (80.00)
Age, years
  ≤60 23 (38.33) 18 (78.26) 1.329 0.249
  >60 37 (61.67) 33 (89.18)
Location
  Upper esophagus 11 (18.33) 8 (72.72) 1.711 0.425
  Median esophagus 28 (46.67) 25 (89.28)
  Lower esophagus 21 (35.00) 18 (85.71)
Histological differentiation
  High 18 (30.00) 12 (66.67) 9.020 0.011
  Moderate 18 (30.00) 15 (83.33)
  Low 24 (40.00) 24 (100.00)
Depth of invasion
  T1a 13 (21.67) 8 (61.53) 8.908 0.012
  T2b 17 (28.33) 14 (82.35)
  T3c 30 (50.00) 29 (96.67)
Lymph node metastasis
  Positive 36 (60.00) 34 (94.44) 6.296 0.012
  Negative 24 (40.00) 17 (70.83)
  Ki-67 expression
  High 53 (88.33) 48 (90.57) 11.039 0.001
  Low 7 (11.67) 3 (42.85)

Depth of the tumor up to

a

mucous and submucosa

b

muscle

c

fibrous membranes and adjacent organs. TSPAN1, tetraspanin 1.